BiomedGrid

  Primary Typical Carcinoid of the Pleura: Case Report Abstract Carcinoid tumors are rare, slow-growing neuroendocrine tumors. The most common location of these tumors is in the gastrointestinal tract and broncho-pulmonary system. Primitive pleural localization is very rare. The majority of cases found in the literature are metastatic forms or relapses. We report the case of a 56-year-old patient with a typical carcinoid tumor of the pleura. Keywords:  Pleura; Typical carcinoid tumor; Multidisciplinary approach Background Carcinoid tumors are a very rare variety of neuroendocrine tumors, most commonly found in the digestive tract and in the lungs [1]. Primary pleural localization is rarely found. Typical carcinoid tumors pose a diagnostic problem. Because of the scarcity of these tumors, this diagnosis is sometimes difficult. Histologically, it is a neuroendocrine tumor whose morphology often joins that in other locations. The prognosis of these tumors are generally pejorative given th

  Real Asymptomatic Patients with COVID-19 Abstract Objective:  To evaluate the clinical features, virological course, and follow-up of COVID-19 patients without symptoms who were admitted to Beijing Ditan hospital, and pays attention to the epidemiological significance of asymptomatic cases. Methods:  10 cases in a cluster who diagnosed COVID-19 were enrolled in Beijing Ditan Hospital on February 27th in 2020. They had a close contact with the same COVID-19 patient. Clinical data were collected, including general status, clinical manifestations, laboratory test results, imaging characteristics, treatment regimens, outcomes, and follow-up. Results:  7 were male and 3 were female, with an age range of 22 to 59 years and a median age of 49 years. Three patients were asymptomatic. The median age of the asymptomatic patients was 52, older than the symptomatic patients (52 vs 40, P = 0.37). 10 patients manifested as pneumonia. 7 cases of double lung and 3 cases of single lung. the asymptoma

  Social and Technological Innovation in Chronic Illness Management during the COVID-19 Pandemic Abstract The current world situation being so affected by the COVID-19 pandemic, personal contact with health care professionals is hard if not impossible for many patients who don’t qualify as emergency cases and just need to continue their regular visits for chronic illness. Medicine has had to adapt as well as other disciplines have done to satisfy human needs. One of the innovative strategies used for this adaptation period has been the use of telemedicine. The aim of this paper was to analyze the available data on telemedicine use worldwide and specifically, in Mexico, to contemplate its helpfulness in providing care for non-communicable diseases. A literature review found several papers that generally agree on the fact that this is a feasible strategy in most cases, including third world countries like Mexico where internet access is not always a given for part of the population at le

  Phage Therapy to Prevent Nosocomial Bacterial Pneumonia in Patients with Severe COVID-19 in 2020 Abstract The COVID-19 was reported to be a pandemic, according to the World Health Organization (WHO). Secondary bacterial pneumonia exacerbates respiratory problems and increases mortality in patients with COVID-19. Recently, 50% of the causes of death in these patients have been reported as nosocomial pneumonia in these cases. These bacteria have become multidrug-resistant. Phage production is a cost-benefit. Inhalation of phage cocktail with mesh nebulizer can be suitable to prevent secondary bacterial pulmonary infection in patients with severe COVID-19. To prevent secondary bacterial pneumonia and reduce mortality in patients with severe type COVID-19 and patients who are under a ventilator for a long time, the use of phage cocktail product by inhalation with mesh nebulizer device is recommended Keywords:  Pneumonia; COVID-19; Prevention; Phage therapy Dear Editor The COVID-19 was re

  General Theory of Inflammation. Patient Education Key to Microdose Therapy for Chronic Inflammation Control Short Communication Microdose therapy is patient self-administration of hydrocortisone with stress management to control chronic inflammation within inflammation disorders [1].   Using microdose therapy, patients require so little hydrocortisone that overdose effects are avoided.  Using this plan, patients average ingesting less hydrocortisone to achieve superior symptom control than low dose, daily hydrocortisone achieves, hence the given name micro dose therapy.  The chronic inflammation cause is the weakening hydrocortisone surge in the blood produced by an activated hypothalamic-pituitary-adrenal (HPA) axis.  As it weakens, short-term, beneficial inflammation increasingly evolves into chronic inflammation.  The HPA axis activates only when stresses as infections, injuries, allergies, and emotional traumas occur.  Much of the time, the axis is relaxed.  The chronic inflammat

  Green Tea and Coronavirus Infection Abstract Keywords:  Covid-19; Camellia Sinensis Complementary medicine Abbreviations:  SARS-CoV-2: Severe Acute Respiratory Syndrome Coronavirus-2; EC: Epicatechin; EGC: Epigallocatechin; ECG: Epicatechin-3- gallate; EGCG: epigallocatechin-3-gallate; MERS-CoV: Middle Eastern Respiratory Syndrome Coronavirus; UPR: Unfolded Protein Response Introduction On the eve of 2020 the world was attacked by a new virus called Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which lead to a pneumonia called ‘covid-19’. Within less than three months, several countries became infected with the virus and Globally, by the time of writing this manuscript, there have been 9,413,289 confirmed cases of COVID-19, including 482,730 deaths, reported to WHO [1]. So far, no definitive treatment or confirmed vaccine has been found for this disease. COVID-19 and influenza viruses have similar disease presentations. They both cause multiorgan diseases especially i

  Health benefits of Leucaena leucocephala Seeds: A scoping review Protocol Abstract Background:  The usage of plants to maintain health has been practiced since long time ago. Leucaena Leucocephala seed is well known for its medicinal benefits. However, the summary of the health benefits rooting back to its phytochemicals components and mechanism of action is limited. This protocol presents the method to conduct scoping review on the health benefits of Leucaena leucocephala seed. Method:  Using Arksey and O’Malley’s scoping review methodology, we will begin the searching process by finding the published articles in the electronic databases (Pubmed, Scopus, Cochrane Library, ClinicalTrials.gov, Google scholar, Lens.org) using selected keywords and defined inclusion criteria. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) diagram (2009) will be used to guide the selection flow. The review process will involve two stages: title and abstract review and sub